They were approved by the U.S. Food and Drug Administration (FDA) around the same time: doxycycline in 1967 and minocycline in 1971. Both medicines have broad-spectrum activity against bacteria ...
The paper was published in European Neuropsychopharmacology. Doxycycline is a broad-spectrum antibiotic in the tetracycline ...
Relative to high-dose doxycycline, low-dose doxycycline is comparably effective but more tolerable for lymphocyti ...